3rd Quarter - Report

340B HEALTH for 340B HEALTH

Firm
Client
Income
—
Expenses
$267,727
Expense method
A: Lobbying Disclosure Act definitions

What was lobbied

One issue area, each in the filer's own words, with who lobbied on it and where.

Pharmacy PHA

HR 444; S 1239; HR 3200; S 1679. Extending the 340B Drug Discount to the Inpatient Setting in DSH Hospitals and improving program integrity Preserving current 340B Patient Defintion Improving Medicaid rebimbursement to 340B covered entities

LobbyistCovered position, as disclosed
VICTORIA AUFIERO —
STUART YAEL GORDON —
ROBERT RECKLAUS Staff for Rep. Carolyn McCarthy (02-08)
TED SLAFSKY Fellow for Sen. Democratic Policy Comm 1994
JAIMIE VICKERY Staff for Reps. Horn and Biggert (00-05)
WILLIAM VON OEHSEN —
BONNIE WEINTRAUB —

Contacted: SENATE; Health & Human Services, Dept of (HHS); HOUSE OF REPRESENTATIVES; Health Resources & Services Administration (HRSA); Centers For Medicare and Medicaid Services (CMS)

Bills named: H.R. 3200 (111th), H.R. 444 (111th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.